Literature DB >> 1915311

Enumeration of 6-thioguanine-resistant T-lymphocytes in the peripheral blood of nonhuman primates (cynomolgus monkeys).

D M Zimmer1, C S Aaron, J P O'Neill, R J Albertini.   

Abstract

We have investigated the use of cynomolgus monkeys (Macaca fascicularis) as a model of somatic cell mutagenesis in non-human primates. Using techniques described by Albertini (Mutation Research 150:411-422, 1985) for similar studies in humans, the frequency of TG-resistant T-lymphocytes in the peripheral blood was determined in animals that were either untreated or treated with ethylnitrosourea. The frequency of TG-resistant cells in untreated males was (mean +/- SD) 6.0 +/- 5.9 per 10(6) cells and for untreated females was 2.9 +/- 2.7 per 10(6) cells. The spontaneous frequency of TG-resistant cells for all animals was 4.2 +/- 4.44 per 10(6) cells. Maximum frequency of TG-resistant cells for two animals treated with a single I.P. dose of ENU was 45.1 and 77.9 per 10(6) cells. Substantial increases in frequencies of TG-resistant cells were not seen until at least 63 days after treatment. The TG-resistant phenotype of clones isolated in the assay was stable after growth for 2 weeks in the absence of selective agent. Many of the TG-resistant clones selected were frozen for future molecular analysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915311     DOI: 10.1002/em.2850180304

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  6 in total

1.  Mutational spectrum at the Hprt locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea.

Authors:  T R Skopek; V E Walker; J E Cochrane; T R Craft; N F Cariello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

2.  Characterization of rat lymphocyte primary culture for the development of an in-vitro mutagenesis assay: effect of interleukin-2 and 2-mercaptoethanol on the activities of intermediary metabolism enzymes and cell proliferation.

Authors:  A Aidoo; R J Feuers; L E Lyn-Cook; M E Bishop; D A Casciano
Journal:  Cell Biol Toxicol       Date:  1996-04       Impact factor: 6.691

3.  End points for biomonitoring: assay sensitivity/selectivity.

Authors:  C S Aaron; D M Zimmer; P R Harbach; R L Yu
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

4.  Mutagenesis after cancer therapy.

Authors:  K T Kelsey; M Caggana; P M Mauch; C N Coleman; J R Clark; H L Liber
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

Review 5.  Risk and benefit evaluation in development of pharmaceutical products.

Authors:  C S Aaron; P R Harbach; S S Mattano; J K Mayo; Y Wang; R L Yu; D M Zimmer
Journal:  Environ Health Perspect       Date:  1993-10       Impact factor: 9.031

Review 6.  Pathology and toxicology of beluga whales from the St. Lawrence Estuary, Quebec, Canada. Past, present and future.

Authors:  D Martineau; S De Guise; M Fournier; L Shugart; C Girard; A Lagacé; P Béland
Journal:  Sci Total Environ       Date:  1994-09-16       Impact factor: 7.963

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.